Widely used:Recently Viewed
Clear All$42.97
$0.00 (0.00%)As on 21-Jun-2024 19:00EDT
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
$1,615 Mln
P/E Ratio
30.05
P/B Ratio
0.89
Industry P/E
--
Debt to Equity
--
ROE
0.03 %
ROCE
3.06 %
Div. Yield
0 %
Book Value
47.71
EPS
1.43
CFO
$2,434.92 Mln
EBITDA
$3,954.08 Mln
Net Profit
$2,262.07 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Taro Pharmaceutical - ADR
| 2.85 | 1.30 | 1.51 | 4.88 | -16.22 | -13.09 | -8.04 |
|
BSE Sensex*
| 2.31 | 4.10 | 4.62 | 8.57 | 11.86 | 20.23 | 11.18 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|
|---|---|---|---|---|---|---|---|
|
Taro Pharmaceutical - ADR
| 43.87 | -42.05 | -31.75 | -16.50 | 3.89 | -19.07 | -0.53 |
|
S&P Small-Cap 600
| 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 | 11.73 |
|
BSE Sensex
| 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 | 27.91 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also... develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug chains, food chains, hospitals, mass merchandisers, e-commerce stores, and other direct consumers, as well as healthcare institutions and private pharmacies. The company was incorporated in 1959 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. operates as a subsidiary of Alkaloida Chemical Company Zrt. As of June 30, 2023, Taro Pharmaceutical Industries Ltd. operates as a subsidiary of Sun Pharmaceutical Industries Limited. Read more
CEO & Director
Mr. Uday V. Baldota
VP, CFO & Chief Accounting Officer
Mr. William J. Coote
Headquarters
Haifa
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Taro Pharmaceutical Industries Ltd - ADR stood at $ 2,162 Mln as on 31-Mar-24
The share price of Taro Pharmaceutical Industries Ltd - ADR is $42.97 (NYSE) as of 21-Jun-2024 19:00 EDT. Taro Pharmaceutical Industries Ltd - ADR has given a return of -16.22% in the last 3 years.
Taro Pharmaceutical Industries Ltd - ADR has a market capitalisation of $ 1,615 Mln as on 10-Jul-2024. As per Value Research classification, it is a Small Cap company.
The P/E ratio of Taro Pharmaceutical Industries Ltd - ADR is 30.05 times as on 10-Jul-2024.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Taro Pharmaceutical Industries Ltd - ADR and enter the required number of quantities and click on buy to purchase the shares of Taro Pharmaceutical Industries Ltd - ADR.
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug chains, food chains, hospitals, mass merchandisers, e-commerce stores, and other direct consumers, as well as healthcare institutions and private pharmacies. The company was incorporated in 1959 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. operates as a subsidiary of Alkaloida Chemical Company Zrt. As of June 30, 2023, Taro Pharmaceutical Industries Ltd. operates as a subsidiary of Sun Pharmaceutical Industries Limited.
The CEO & director of Mr. Uday V. Baldota. is Taro Pharmaceutical Industries Ltd - ADR, and CFO & Sr. VP is Mr. William J. Coote.
There is no promoter pledging in Taro Pharmaceutical Industries Ltd - ADR.
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|
| Taro Pharmaceutical Industries Ltd. - ADR | Ratios |
|---|---|
|
Return on equity(%)
|
3.06
|
|
Operating margin(%)
|
--
|
|
Net Margin(%)
|
--
|
|
Dividend yield(%)
|
--
|
Yes, TTM profit after tax of Taro Pharmaceutical Industries Ltd - ADR was $54 Mln.
